Zydus Cadila gets USFDA nod for generic mental disorders drug
The drug, lurasidone hydrochloride tablets, will be manufactured at the group's manufacturing facility at SEZ, Ahmedabad
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
USFDA classifies Jubilant Life’s Nanjangud facility as ‘Official Action Indicated’
The USFDA also stated that the facility might be subject to a cGMP regulatory or enforcement action based on this inspection
Lupin launches Levothyroxine Sodium tablets in US
The company's product is the generic version of AbbVie Inc's Synthroid tablets
DuPont releases clinical study results demonstrating benefits of high-potency and multi-strain…
Nutrients journal publishes new study suggesting higher doses of a DuPont multispecies probiotic formulation may permit more…
HC seeks Centre’s reply on PETA plea against use of horses for producing anti-venoms
People for the Ethical Treatment of Animals (PETA) has sought directions to the Centre to exclude animal-based production…
Zydus Cadila gets USFDA nod to market generic antiviral ointment
Antiviral drug Acyclovir is used to treat the first outbreak of genital herpes infection and to treat non-life threatening herpes…
Abbott introduces new digital service in India
The a:care platform will provide doctors and consumers with services and information to help people achieve better health
Alembic Pharma raises Rs 150 crore via NCDs
The NCDs carry a coupon rate of 8.37 per cent per annum and are proposed to be listed on NSE
C2 Pharma acquires Digoxin API Portfolio from Nobilus Ent to guarantee long-term quality and supply…
A fully redundant supply of Digoxin API from C2 PHARMA will be available via two CMO manufacturing sources at Nobilus in Poland…
Indian Pharma Industry witnesses new trends introduced by Schott Kaisha
One-of-its kind roadshow hosted more than 500 customers, partners and prospects under one roof in Ahmedabad, Bengaluru,…